Few companies, however, have demonstrated that they are prepared to commit the time, effort, and resources to embrace a radically different way of operating. Yet the tangible and intangible benefits of adopting new forms of collaboration – reducing the cost of failure, leveraging unused IP and external funding mechanisms, increasing access to networks of talent, and establishing greater trust among patients and other stakeholders – could be extensive.
但现在还没有几家公司表示，他们准备投入时间、精力和资源实行一种完全不同的运营方式。采取这种新的合作方式，其带来的有形和无形的利润都很可观，包括降低失败成本，平衡未使用过的知识产权和外部资助机制，增加人才使用的渠道，以及在患者和其它利益相关者之间建立更大的信任等。另外，从中受益的不仅仅是制药公司，还包括学术界和其它合作机构。